跳至主要内容
临床试验/EUCTR2012-001809-24-NL
EUCTR2012-001809-24-NL进行中(未招募)不适用

Evaluation of urinary concentrating defects in lithium treated patients with a dDAVP test - Nephrogenic diabetes insipidus (NDI) in lithium treated patients

Radboud University Nijmegen Medical Centre0 个研究点开始时间: 2012年9月6日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ?stable patients with a mood disorder treated with lithium
  • ?men and women
  • ?age = 18 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 100

排除标准

  • ?general contra-indications for participation in a trial:
  • oinability to give informed consent
  • ounstable psychiatric condition
  • ?alternative causes of (nephrogenic) diabetes insipidus:
  • ohypo/hyperkalemia (plasma potassium < 3.5 or > 5.5 mmol/l)
  • osevere hypercalcemia (albumin-corrected plasma calcium > 2.80 mmol/l)
  • ohyperglycemia (plasma glucose > 10.0 mmol/l)
  • ohistory of amyloidosis, Sjögren’s syndrome or Sickle cell anemia
  • oprevious treatment with ifosfamide
  • oestablished primary polydipsia or central diabetes insipidus
  • ?contra-indications for dDAVP administration:
  • oinability to comply with water restriction
  • orenal insufficiency (GFR < 45 ml/min/1.73 m2)
  • ohyponatremia (plasma sodium < 130 mmol/l
  • oconcomitant treatment with desmopressin or democlocycline

研究者

发起方
Radboud University Nijmegen Medical Centre

相似试验